Paydirt
RH
Insider

Reid M Huber

Director

Reid M Huber (Director) filed 1 Form 4 report in the past 24 months (1 purchase, 0 sales), most often in Rapport Therapeutics, Inc. (RAPP). Across 1 priced purchase filing, the average 21-session return was +9.3% from execution and +10.2% from disclosure (delay-adjusted; derived). The largest single filing was $499K of RAPP (20,400 sh × $24.48, as filed), executed Sep 12 2025.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
+9.3%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+10.2%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells
Median delay
3d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$499K
shares × price, as filed
Last traded
Sep 12 2025
Filed Sep 15 2025

Median ADV $17.2M across their filed names

Open performance
Volume by month
$499K$250K$0Oct 2024Apr 2025Oct 2025Apr 2026Sep 2025 · buys $499K
Buys $499K Sells $0

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 1 filing

Sector per market data · by filing · past 24 months

Most traded names
RAPP Rapport Therapeutics, Inc. RAPP · 1 buy · 0 sells 1 filing
Recent filings
RAPPPURCHASE Rapport Therapeutics, Inc. View filing → $499K
20,400 sh × $24.48
Exec Sep 12 2025
Filed Sep 15 2025 · 4:05 PM ET